We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

RETN rs1862513: What Your Genotype Means for Dietary Response

rs1862513
Trait
Limited evidenceGene: RETN

The rs1862513 variant is a single nucleotide polymorphism located in the RETN gene, which encodes the protein resistin. It has been studied for its potential role in modulating individual metabolic responses to low-fat versus high-MUFA dietary interventions.

What each genotype means

C/CLower attention

Typical resistin expression

This genotype represents the common form of the RETN promoter variant. Research into this variant is limited and results regarding its influence on metabolic traits or dietary response remain inconsistent across different populations. This finding should not be used to make health decisions; please consult with a healthcare professional regarding any metabolic concerns.

Carried by approximately 45-50% of the population, depending on ancestral background.

C/GLower attention

Heterozygous resistin variant

Carrying one copy of the G allele at this position has been studied for potential links to resistin levels and metabolic responses, though evidence remains limited and sometimes conflicting. The functional impact of this specific change on your health is not well-established. Discuss any specific metabolic or dietary questions with your doctor or a registered dietitian.

Carried by approximately 40-45% of the population, depending on ancestral background.

G/GLower attention

Minor allele resistin variant

This genotype represents the less common form of the variant. While some studies have explored whether this variant modulates responses to dietary interventions or metabolic markers, the evidence is currently limited and not definitive. This result does not provide a clinical diagnosis; please speak with a clinician if you have concerns about your metabolic health.

Carried by approximately 5-10% of the population, depending on ancestral background.

What is rs1862513 and Where is it Located?

The genetic variant rs1862513 is a single nucleotide polymorphism (SNP) found within the RETN gene on human chromosome 19. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. Specifically, at this location, the DNA base can be either a Cytosine (C) or a Guanine (G). The RETN gene provides instructions for producing the protein resistin. This variant sits in a region that may influence how much of this protein is produced or how it functions. Because chromosomes come in pairs—one inherited from each parent—an individual will have one of three possible genotypes at this site: CC, CG, or GG. Researchers study these specific differences to determine if they correlate with observable traits, such as metabolic responses to different types of dietary fats, helping to build a broader map of human genetic diversity.

The Role of the RETN Gene and Resistin

The RETN gene encodes resistin, a hormone-like protein that belongs to the family of cysteine-rich secretory proteins. Originally named "resistin" because it was thought to induce insulin resistance in rodents, its role in human metabolism has been a subject of intense scientific investigation. In humans, resistin is primarily secreted by adipose tissue (fat cells) and immune cells, and it is believed to play a role in inflammation and the regulation of metabolic processes. Because resistin levels can fluctuate based on body mass and health status, scientists have examined whether genetic variants like rs1862513 alter the expression or stability of this protein. While the protein is clearly involved in metabolic pathways, the exact mechanism by which this specific SNP might modify human physiology is not fully understood. Research continues to explore how genetic variations in RETN interact with environmental factors, such as diet, to influence health outcomes.

Associations With Dietary Response

The GWAS Catalog and various clinical studies have explored the association between rs1862513 and dietary interventions. Specifically, some research has investigated whether this variant modulates an individual's metabolic response to diets high in monounsaturated fatty acids (MUFA) versus low-fat diets. The evidence strength for this association is currently classified as limited. While early studies suggested that the G allele might be linked to different outcomes regarding weight management or lipid profiles when comparing these dietary patterns, these findings have not been consistently replicated across all populations. It is important to interpret these associations with caution; "limited evidence" means that while a signal was observed in a specific cohort, more robust, large-scale studies are required to confirm if this variant has a clinically meaningful impact on health. This field is evolving, and genetic associations should not be viewed as deterministic factors in nutritional planning.

Practical Implications for the Reader

If you have received results for rs1862513, it is vital to remember that genetic information is not a medical diagnosis. The current scientific consensus classifies the evidence for this variant as limited, meaning it is not a validated tool for personalized nutrition or medical decision-making. You cannot use this information to definitively predict how you will respond to specific fats or to determine your risk for metabolic conditions. Factors such as physical activity, total caloric intake, underlying health conditions, and overall lifestyle play a much larger role in your well-being than this single SNP. If you are concerned about your diet, weight, or metabolic health, always consult with a registered dietitian or a healthcare professional. These experts can provide guidance based on your total health profile rather than a single genetic marker. Always speak with your doctor before making significant changes to your nutrition or lifestyle.

How common is this variant?

The rs1862513 variant is relatively common, with an approximate population frequency of 30% for the minor allele, though this varies significantly by ancestry.

Frequently asked questions

Is rs1862513 a predictor of weight loss success?

No, rs1862513 is not a reliable predictor of weight loss success. While some studies have explored its potential impact on dietary responses, the evidence is limited, and genetics is only one of many factors that influence metabolic health.

Can I change my diet based on my rs1862513 genotype?

You should not change your diet based solely on this genetic variant. Nutritional needs are complex, and scientific research has not established that this SNP provides enough actionable data to guide dietary protocols.

Where can I find more information about this SNP?

You can explore reputable databases such as the GWAS Catalog or dbSNP for peer-reviewed studies. These resources provide the most accurate and up-to-date data on how rs1862513 is being studied in the scientific community.

Is this variant associated with any diseases?

The variant is primarily studied in the context of metabolic traits and dietary interaction. It is not currently linked to specific diseases in a way that would alter clinical diagnosis or treatment.

Sources & further reading

Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs1862513?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29